Prothixene

This classification denotes a sedative and hypnotic with the molecular formula C18H19NS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2HX2OJH78L, chemically known as n,n-dimethylthioxanthene-delta(sup 9,gamma)-propylamine but generally known as prothixene, which bears US NIH Compound Identifier 71115. European Medicines Agency schedules Prothixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10139MIG. The term PROTHIXENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PROTHIXENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prothixene under HS 29349990 and SITC 51579. As of Q4 2014, PROTHIXENE remains the US FDA Preferred Term for this commodity. Prothixene bears US NLM identifiers UMLS ID C0072428 and NCI Concept Code C73249. SMILES: S1C2C(C(=C\CCN(C)C)/C3C1CCCC3)CCCC2.